Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
December 08 2023 - 4:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant x
Filed by a Party other than the Registrant
¨
Check the appropriate box:
|
¨ |
Preliminary Proxy Statement |
|
¨ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
¨ |
Definitive Proxy Statement |
|
x |
Definitive Additional Materials |
|
¨ |
Soliciting Material under §240.14a-12 |
Bio-Path Holdings, Inc. |
(Name of Registrant as Specified in its Charter) |
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) |
Payment of Filing Fee (Check the appropriate box):
|
x |
No fee required. |
|
¨ |
Fee paid previously with preliminary materials. |
|
¨ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Bio-Path Holdings, Inc.
4710 Bellaire Boulevard, Suite 210
Bellaire, Texas 77401
SUPPLEMENT TO PROXY STATEMENT
FOR ANNUAL MEETING OF SHAREHOLDERS
On December 7, 2023,
the Board of Directors of Bio-Path Holdings, Inc. (the “Company”) approved an amendment to
the Company’s First Amended and Restated Bylaws to reduce the quorum needed for stockholder meetings to one-third of the shares
entitled to vote at a meeting of stockholders. The quorum requirement will apply to the 2023 Annual Meeting of Stockholders (the “Annual
Meeting”) to be held on Thursday, December 14, 2023 at 4:00 p.m., Central Standard Time, at Winstead PC, 24 Waterway Avenue,
Suite 500, The Woodlands, Texas 77380.
If you have voted by proxy
already, your vote will be counted and there is no need to take any further action. If for any reason you wish to revoke your proxy, please
follow the instructions in the Company’s Proxy Statement for the Annual Meeting dated October 27, 2023 (the “Proxy Statement”),
which was filed with the Securities and Exchange Commission on October 27, 2023. The Proxy Statement is also available at http://www.astproxyportal.com/ast/22620/.
This document amends and supplements
the Proxy Statement to reflect the new quorum requirement applicable to the Annual Meeting.
The second paragraph under
the heading “Quorum and Voting” on page seven of the Proxy Statement is hereby amended to read in full as follows:
“We must have a “quorum”
to conduct business at the Annual Meeting. In order for there to be a quorum at the Annual Meeting, the holders of one-third of the outstanding
shares of common stock entitled to vote at the Annual Meeting must be present in person or by proxy. Stockholders of record who are present
at the Annual Meeting in person or by proxy, including those who abstain from voting, including brokers holding customers’ shares
of record who cause abstentions to be recorded at the Annual Meeting, will be included in the number of stockholders present at the Annual
Meeting for purposes of determining whether a quorum is present.”
The record date for the Annual Meeting remains
as October 23, 2023.
We encourage you to read all
of our proxy materials, including our Proxy Statement, so that you may be informed about the business to come before the Annual Meeting.
Your participation in our business is important, regardless of the number of shares that you hold. We urge you to vote regardless of
whether you expect to attend the Annual Meeting so that we may ensure that a quorum is present.
Bio Path (NASDAQ:BPTH)
Historical Stock Chart
From Apr 2024 to May 2024
Bio Path (NASDAQ:BPTH)
Historical Stock Chart
From May 2023 to May 2024